GlobalCODE helps you unify your clinical data and accelerate scientific discovery.

1. can you answer
these questions?
Specimen Status▸
▸ Where, how much,
storage state?
Informed Consent
and Regulatory▸
▸ Can I do additional testing
on those specimens?▸
▸ Which sites made changes
to master IC document?▸
▸ What were regulations
at time of draw?
Site Performance▸
▸ What are my sites doing?
How does it compare
to other studies?
Scalable Solution?▸
▸ IT development and
customization costs
for data aggregation can
easily be in $10s of millions
Missing specimens▸
▸ Did the site collect
the right specimens?▸
▸ Did the labs receive
all of them?
How do my results compare?▸
▸ How is my assay working in this
trial compared to others?
Do I have more
specimens like these?▸
▸ Can I avoid buying
characterized specimens?

2. Biorepository
Status
Collection Data
Consent & MTA Biomarker Results
Logistics & Tracking
Patient
Demographic DataCOE
GlobalcoDe®
End-to-End Lifecycle
Specimen Management
Unified Data, Single Interface▸▸▸
▸ Cloud-based specimen tracking
▸ Cross-protocol analysis tools
▸ Informed consent management
Better, Smarter Data Management▸▸▸
▸ Eliminate missing, disorganized and scattered data
▸ Spend less time gathering data, more time analyzing it
▸ Advance your research and your business
Discover Hidden ROI▸
▸ Avoid cost and risk of custom systems▸
▸ Focus on key mission of discovery
and commercialization
GlobalCODE®
helps you unify your data and
accelerate scientific discovery
Learn more about our drug development solutions at www.covance.com
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory
Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing
name for Covance Inc. and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623) +1.609.452.4440
Europe/Africa +00.800.2682.2682 +44.1423.500888
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2019 Covance Inc. SSCLS052-0619